134 related articles for article (PubMed ID: 27133044)
1. miR-195 inhibits tumor growth and angiogenesis through modulating IRS1 in breast cancer.
Wang Y; Zhang X; Zou C; Kung HF; Lin MC; Dress A; Wardle F; Jiang BH; Lai L
Biomed Pharmacother; 2016 May; 80():95-101. PubMed ID: 27133044
[TBL] [Abstract][Full Text] [Related]
2. MiR-30e inhibits tumor growth and chemoresistance via targeting IRS1 in Breast Cancer.
Liu MM; Li Z; Han XD; Shi JH; Tu DY; Song W; Zhang J; Qiu XL; Ren Y; Zhen LL
Sci Rep; 2017 Nov; 7(1):15929. PubMed ID: 29162879
[TBL] [Abstract][Full Text] [Related]
3. A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.
Xu Q; Jiang Y; Yin Y; Li Q; He J; Jing Y; Qi YT; Xu Q; Li W; Lu B; Peiper SS; Jiang BH; Liu LZ
J Mol Cell Biol; 2013 Feb; 5(1):3-13. PubMed ID: 22935141
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1.
Yin Y; Yan ZP; Lu NN; Xu Q; He J; Qian X; Yu J; Guan X; Jiang BH; Liu LZ
Biochim Biophys Acta; 2013 Feb; 1829(2):239-47. PubMed ID: 23201159
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling.
Wang Y; Hu C; Cheng J; Chen B; Ke Q; Lv Z; Wu J; Zhou Y
Biochem Biophys Res Commun; 2014 Apr; 446(4):1255-60. PubMed ID: 24690171
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-664 Targets Insulin Receptor Substrate 1 to Suppress Cell Proliferation and Invasion in Breast Cancer.
Wu L; Li Y; Li J; Ma D
Oncol Res; 2019 Mar; 27(4):459-467. PubMed ID: 29495974
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-145 Negatively Regulates Cell Proliferation Through Targeting IRS1 in Isolated Ovarian Granulosa Cells From Patients With Polycystic Ovary Syndrome.
Cai G; Ma X; Chen B; Huang Y; Liu S; Yang H; Zou W
Reprod Sci; 2017 Jun; 24(6):902-910. PubMed ID: 27799458
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic role of miR-20a in breast cancer.
Luengo-Gil G; Gonzalez-Billalabeitia E; Perez-Henarejos SA; Navarro Manzano E; Chaves-Benito A; Garcia-Martinez E; Garcia-Garre E; Vicente V; Ayala de la Peña F
PLoS One; 2018; 13(4):e0194638. PubMed ID: 29617404
[TBL] [Abstract][Full Text] [Related]
9. Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs.
Aslan C; Maralbashi S; Kahroba H; Asadi M; Soltani-Zangbar MS; Javadian M; Shanehbandi D; Baradaran B; Darabi M; Kazemi T
Life Sci; 2020 Oct; 258():118094. PubMed ID: 32673663
[TBL] [Abstract][Full Text] [Related]
10. miR-497 suppresses angiogenesis in breast carcinoma by targeting HIF-1α.
Wu Z; Cai X; Huang C; Xu J; Liu A
Oncol Rep; 2016 Mar; 35(3):1696-702. PubMed ID: 26718330
[TBL] [Abstract][Full Text] [Related]
11. The 14q32 microRNA-487b targets the antiapoptotic insulin receptor substrate 1 in hypertension-induced remodeling of the aorta.
Nossent AY; Eskildsen TV; Andersen LB; Bie P; Brønnum H; Schneider M; Andersen DC; Welten SM; Jeppesen PL; Hamming JF; Hansen JL; Quax PH; Sheikh SP
Ann Surg; 2013 Nov; 258(5):743-51; discussion 752-3. PubMed ID: 24096771
[TBL] [Abstract][Full Text] [Related]
12. MiR-383 inhibits proliferation, migration and angiogenesis of glioma-exposed endothelial cells in vitro via VEGF-mediated FAK and Src signaling pathways.
Zhao LN; Wang P; Liu YH; Cai H; Ma J; Liu LB; Xi Z; Li ZQ; Liu XB; Xue YX
Cell Signal; 2017 Jan; 30():142-153. PubMed ID: 27693218
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell-secreted angiogenin induces angiogenic activity of endothelial cells by suppressing miR-542-3p.
He T; Qi F; Jia L; Wang S; Wang C; Song N; Fu Y; Li L; Luo Y
Cancer Lett; 2015 Nov; 368(1):115-125. PubMed ID: 26272182
[TBL] [Abstract][Full Text] [Related]
14. Annexin-A1 regulates microRNA-26b* and microRNA-562 to directly target NF-κB and angiogenesis in breast cancer cells.
Anbalagan D; Yap G; Yuan Y; Pandey VK; Lau WH; Arora S; Bist P; Wong JS; Sethi G; Nissom PM; Lobie PE; Lim LH
PLoS One; 2014; 9(12):e114507. PubMed ID: 25536365
[TBL] [Abstract][Full Text] [Related]
15. [miR-126 inhibits colon cancer proliferation and invasion through targeting IRS1, SLC7A5 and TOM1 gene].
Li N; Li X; Huang S; Shen S; Wang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 38(8):809-17. PubMed ID: 23981989
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11.
Siragam V; Rutnam ZJ; Yang W; Fang L; Luo L; Yang X; Li M; Deng Z; Qian J; Peng C; Yang BB
Oncotarget; 2012 Nov; 3(11):1370-85. PubMed ID: 23211491
[TBL] [Abstract][Full Text] [Related]
17. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
[TBL] [Abstract][Full Text] [Related]
18. Dual targeting of ANGPT1 and TGFBR2 genes by miR-204 controls angiogenesis in breast cancer.
Flores-Pérez A; Marchat LA; Rodríguez-Cuevas S; Bautista-Piña V; Hidalgo-Miranda A; Ocampo EA; Martínez MS; Palma-Flores C; Fonseca-Sánchez MA; Astudillo-de la Vega H; Ruíz-García E; González-Barrios JA; Pérez-Plasencia C; Streber ML; López-Camarillo C
Sci Rep; 2016 Oct; 6():34504. PubMed ID: 27703260
[TBL] [Abstract][Full Text] [Related]
19. Deregulated expression of miR-145 in manifold human cancer cells.
Xing AY; Wang B; Shi DB; Zhang XF; Gao C; He XQ; Liu WJ; Gao P
Exp Mol Pathol; 2013 Aug; 95(1):91-7. PubMed ID: 23714355
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-874 inhibits cell proliferation and induces apoptosis in human breast cancer by targeting CDK9.
Wang L; Gao W; Hu F; Xu Z; Wang F
FEBS Lett; 2014 Dec; 588(24):4527-35. PubMed ID: 25281924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
